[{"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-001", "question": "A 45-year-old man with a history of bipolar disorder presents with acute agitation, auditory hallucinations, and disorganized thinking after discontinuing his lithium therapy 2 weeks ago. He has a serum creatinine of 1.8 mg/dL and reports recent use of ibuprofen for headaches. Which of the following is the most appropriate initial management?", "options": ["Administer haloperidol intramuscularly", "Restart lithium at half the previous dose", "Initiate valproic acid orally", "Perform hemodialysis", "Administer lorazepam intravenously"], "answer": "D", "answer_index": 3, "explanation": "Hemodialysis is indicated due to lithium toxicity exacerbated by NSAID-induced renal impairment, leading to elevated lithium levels causing neurotoxicity. Haloperidol and lorazepam address symptoms but not the underlying toxicity, while restarting lithium or starting valproic acid risks worsening the condition without clearance.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K. Verdict on keyed answer: Miskeyed. Key stem clues: 45-year-old with bipolar disorder discontinued lithium 2 weeks ago, presenting with acute agitation, auditory hallucinations, disorganized thinking; serum creatinine 1.8 mg/dL, recent ibuprofen use. No mention of lithium level, typical toxicity symptoms (e.g., tremor, ataxia), or ongoing lithium intake. Main logical issue(s): The stem supports a relapse of bipolar mania with psychotic features, making haloperidol IM (A) the unique best initial management for addressing both agitation and hallucinations; however, the key (D) incorrectly selects hemodialysis, which is not indicated without evidence of current lithium toxicity. No internal contradictions, but key mismatches the defensible best answer. Main medical accuracy issue(s): Rationale erroneously assumes persistent lithium toxicity 2 weeks post-discontinuation, implausible given lithium's half-life (18-50 hours, cleared after multiple half-lives even with mild renal impairment); symptoms align with manic relapse, not neurotoxicity. This misleads on pharmacokinetics and toxicity management. Minimal fix: Modify stem to include 'serum lithium level 3.0 mEq/L' to justify toxicity and make D the unique best answer.\",\n  \"medical_accuracy_score\": 2,\n  \"logical_validity\": false,\n  \"logical_false_reason\": \"K\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K. Verdict on keyed answer: Miskeyed. Key stem clues: 45-year-old with bipolar disorder discontinued lithium 2 weeks ago, presenting with acute agitation, auditory hallucinations, disorganized thinking; serum creatinine 1.8 mg/dL, recent ibuprofen use. No mention of lithium level, typical toxicity symptoms (e.g., tremor, ataxia), or ongoing lithium intake. Main logical issue(s): The stem supports a relapse of bipolar mania with psychotic features, making haloperidol IM (A) the unique best initial management for addressing both agitation and hallucinations; however, the key (D) incorrectly selects hemodialysis, which is not indicated without evidence of current lithium toxicity. No internal contradictions, but key mismatches the defensible best answer. Main medical accuracy issue(s): Rationale erroneously assumes persistent lithium toxicity 2 weeks post-discontinuation, implausible given lithium's half-life (18-50 hours, cleared after multiple half-lives even with mild renal impairment); symptoms align with manic relapse, not neurotoxicity. This misleads on pharmacokinetics and toxicity management. Minimal fix: Modify stem to include 'serum lithium level 3.0 mEq/L' to justify toxicity and make D the unique best answer.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-002", "question": "A 32-year-old woman with schizophrenia on clozapine develops fever, tachycardia, and muscle rigidity. Laboratory findings include elevated creatine kinase and leukocytosis. Which rare adverse effect is most likely responsible, and what is the next step in management?", "options": ["Agranulocytosis; discontinue clozapine and start G-CSF", "Neuroleptic malignant syndrome; administer dantrolene and bromocriptine", "Serotonin syndrome; give cyproheptadine", "Catatonia; initiate electroconvulsive therapy", "Myocarditis; perform echocardiography and stop clozapine"], "answer": "B", "answer_index": 1, "explanation": "Neuroleptic malignant syndrome is the diagnosis, requiring immediate supportive care with dantrolene for rigidity and bromocriptine for dopamine agonism. Agranulocytosis presents with infection without rigidity, serotonin syndrome lacks CK elevation typically, catatonia is behavioral, and myocarditis involves cardiac symptoms primarily.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include fever, tachycardia, muscle rigidity, elevated creatine kinase (CK), and leukocytosis in a patient on clozapine for schizophrenia, classically indicating neuroleptic malignant syndrome (NMS) as the rare adverse effect. The question asks for the most likely effect and next management step, with option B correctly identifying NMS and appropriate interventions (dantrolene for rigidity and bromocriptine for dopamine agonism). No main logical issues; the vignette provides sufficient discriminating findings without contradictions, allowing a single best answer without unstated assumptions. Alternatives are inferior: A (agranulocytosis) lacks rigidity/CK elevation and presents with neutropenia; C (serotonin syndrome) typically involves serotonergic agents and less CK rise; D (catatonia) is behavioral without autonomic instability; E (myocarditis) focuses on cardiac symptoms without rigidity. No main medical accuracy issues; aligns with current guidelines (e.g., NMS as a clozapine risk, supportive care including dantrolene/bromocriptine per standard texts like UpToDate). Item is clinically realistic and board-relevant. Minimal fix: None needed, as the item is already unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include fever, tachycardia, muscle rigidity, elevated creatine kinase (CK), and leukocytosis in a patient on clozapine for schizophrenia, classically indicating neuroleptic malignant syndrome (NMS) as the rare adverse effect. The question asks for the most likely effect and next management step, with option B correctly identifying NMS and appropriate interventions (dantrolene for rigidity and bromocriptine for dopamine agonism). No main logical issues; the vignette provides sufficient discriminating findings without contradictions, allowing a single best answer without unstated assumptions. Alternatives are inferior: A (agranulocytosis) lacks rigidity/CK elevation and presents with neutropenia; C (serotonin syndrome) typically involves serotonergic agents and less CK rise; D (catatonia) is behavioral without autonomic instability; E (myocarditis) focuses on cardiac symptoms without rigidity. No main medical accuracy issues; aligns with current guidelines (e.g., NMS as a clozapine risk, supportive care including dantrolene/bromocriptine per standard texts like UpToDate). Item is clinically realistic and board-relevant. Minimal fix: None needed, as the item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-003", "question": "A 65-year-old man undergoes laparoscopic cholecystectomy for acute cholecystitis. Intraoperatively, there is significant bleeding from the cystic artery that is difficult to control. Postoperative imaging reveals a pseudoaneurysm. What is the most appropriate intervention?", "options": ["Endoscopic retrograde cholangiopancreatography with stenting", "Angiographic embolization", "Surgical re-exploration with ligation", "Percutaneous transhepatic cholangiography", "Observation with serial imaging"], "answer": "B", "answer_index": 1, "explanation": "Angiographic embolization is preferred for postoperative pseudoaneurysm to minimize invasiveness and control bleeding effectively. Surgical re-exploration carries higher morbidity, ERCP addresses biliary issues not vascular, PTC is for drainage, and observation risks rupture.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. The clinical problem is identifying the most appropriate intervention for a postoperative cystic artery pseudoaneurysm following laparoscopic cholecystectomy with intraoperative bleeding. Key stem clues: 65-year-old man with acute cholecystitis, significant intraoperative cystic artery bleeding difficult to control, and postoperative imaging confirming pseudoaneurysm—driving need for vascular control to prevent rupture or further hemorrhage. These findings imply a vascular complication best managed minimally invasively. Keyed answer B (angiographic embolization) fits as it directly addresses the pseudoaneurysm with effective, low-morbidity embolization; assumes standard access and no contraindications. Alternatives: A (ERCP with stenting) targets biliary not vascular issues; C (surgical re-exploration) is more invasive with higher risks; D (PTC) is for biliary drainage, irrelevant here; E (observation) risks rupture without intervention. Logical validity: V, as stem allows unique best answer B without contradictions, underspecification, or multiple defensible options. No main logical issues. Medical accuracy: Consistent with current guidelines (e.g., Society of Interventional Radiology standards); embolization is preferred first-line for hepatic artery pseudoaneurysms post-cholecystectomy, avoiding surgical morbidity. No inaccuracies or outdated elements. Minimal fix: No fix required; item is already unambiguous and accurate, but adding 'of the cystic artery' to the pseudoaneurysm description in the stem would enhance precision.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. The clinical problem is identifying the most appropriate intervention for a postoperative cystic artery pseudoaneurysm following laparoscopic cholecystectomy with intraoperative bleeding. Key stem clues: 65-year-old man with acute cholecystitis, significant intraoperative cystic artery bleeding difficult to control, and postoperative imaging confirming pseudoaneurysm—driving need for vascular control to prevent rupture or further hemorrhage. These findings imply a vascular complication best managed minimally invasively. Keyed answer B (angiographic embolization) fits as it directly addresses the pseudoaneurysm with effective, low-morbidity embolization; assumes standard access and no contraindications. Alternatives: A (ERCP with stenting) targets biliary not vascular issues; C (surgical re-exploration) is more invasive with higher risks; D (PTC) is for biliary drainage, irrelevant here; E (observation) risks rupture without intervention. Logical validity: V, as stem allows unique best answer B without contradictions, underspecification, or multiple defensible options. No main logical issues. Medical accuracy: Consistent with current guidelines (e.g., Society of Interventional Radiology standards); embolization is preferred first-line for hepatic artery pseudoaneurysms post-cholecystectomy, avoiding surgical morbidity. No inaccuracies or outdated elements. Minimal fix: No fix required; item is already unambiguous and accurate, but adding 'of the cystic artery' to the pseudoaneurysm description in the stem would enhance precision.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-004", "question": "A 50-year-old woman with Crohn's disease presents with an enterocutaneous fistula after ileocolic resection. She is hemodynamically stable but has high-output fistula drainage. Which management strategy is most effective for promoting spontaneous closure?", "options": ["Total parenteral nutrition and somatostatin analog", "Immediate surgical closure with bowel resection", "Antibiotic therapy with abscess drainage", "Hyperbaric oxygen therapy", "Fibrin glue injection into the fistula tract"], "answer": "A", "answer_index": 0, "explanation": "TPN and somatostatin analogs reduce gastrointestinal secretions and promote fistula healing in high-output cases. Surgical closure is reserved for failures, antibiotics address infection not closure, hyperbaric oxygen lacks evidence, and fibrin glue is for low-output fistulas.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: 50-year-old woman with Crohn's disease develops enterocutaneous fistula post-ileocolic resection; hemodynamically stable with high-output drainage. These drive selection of conservative management to promote spontaneous closure, emphasizing reduction of gastrointestinal secretions in a stable patient without infection or abscess mentioned. Main logical issues: None; the stem is coherent, supports a unique best answer (A), with options discriminable based on evidence for high-output fistulas—surgery (B) is reserved for failures, antibiotics (C) target infection not closure, hyperbaric oxygen (D) lacks strong evidence, and fibrin glue (E) suits low-output cases. Main medical accuracy issues: None; aligns with current guidelines (e.g., ASCRS) recommending TPN and somatostatin analogs (like octreotide) as first-line for high-output fistulas to decrease output and facilitate healing, consistent with mainstream standards without inaccuracies or outdated elements. Minimal fix: None required; item is already unambiguous and accurate.\\n\\nBest-answer defensibility: a) The question asks for the most effective strategy to promote spontaneous closure of a high-output enterocutaneous fistula in a stable Crohn's patient. b) Discriminating findings: Post-surgical fistula in Crohn's, high-output, stable hemodynamics (no sepsis/abscess noted). c) Implied: Conservative therapy reducing fistula output. d) Keyed A fits by providing bowel rest (TPN) and secretion inhibition (somatostatin), assuming no contraindications. e) B worse as immediate surgery risks complications; C incorrect without infection; D unproven; E not for high-output.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: 50-year-old woman with Crohn's disease develops enterocutaneous fistula post-ileocolic resection; hemodynamically stable with high-output drainage. These drive selection of conservative management to promote spontaneous closure, emphasizing reduction of gastrointestinal secretions in a stable patient without infection or abscess mentioned. Main logical issues: None; the stem is coherent, supports a unique best answer (A), with options discriminable based on evidence for high-output fistulas—surgery (B) is reserved for failures, antibiotics (C) target infection not closure, hyperbaric oxygen (D) lacks strong evidence, and fibrin glue (E) suits low-output cases. Main medical accuracy issues: None; aligns with current guidelines (e.g., ASCRS) recommending TPN and somatostatin analogs (like octreotide) as first-line for high-output fistulas to decrease output and facilitate healing, consistent with mainstream standards without inaccuracies or outdated elements. Minimal fix: None required; item is already unambiguous and accurate.\n\nBest-answer defensibility: a) The question asks for the most effective strategy to promote spontaneous closure of a high-output enterocutaneous fistula in a stable Crohn's patient. b) Discriminating findings: Post-surgical fistula in Crohn's, high-output, stable hemodynamics (no sepsis/abscess noted). c) Implied: Conservative therapy reducing fistula output. d) Keyed A fits by providing bowel rest (TPN) and secretion inhibition (somatostatin), assuming no contraindications. e) B worse as immediate surgery risks complications; C incorrect without infection; D unproven; E not for high-output.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-005", "question": "A 60-year-old man with diabetes presents with sudden painless vision loss in the right eye. Fundoscopy shows macular edema and neovascularization at the disc. Optical coherence tomography confirms vitreomacular traction. What is the most appropriate initial treatment?", "options": ["Intravitreal anti-VEGF injection", "Panretinal photocoagulation", "Pars plana vitrectomy", "Intravitreal corticosteroid", "Observation with follow-up"], "answer": "C", "answer_index": 2, "explanation": "Pars plana vitrectomy addresses vitreomacular traction in proliferative diabetic retinopathy with macular involvement, relieving traction and allowing further therapy. Anti-VEGF and laser treat neovascularization but not traction, corticosteroids risk complications, and observation may worsen vision.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Ophthalmology", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K. Verdict on keyed answer: Miskeyed. The clinical problem is determining the most appropriate initial treatment for a 60-year-old diabetic man with sudden painless right eye vision loss, macular edema, disc neovascularization, and vitreomacular traction on OCT, consistent with proliferative diabetic retinopathy (PDR) and diabetic macular edema (DME) with traction. Key stem clues: diabetes history, acute painless vision loss, fundoscopic macular edema and NVD, OCT-confirmed VMT; no mention of vitreous hemorrhage, tractional retinal detachment, or severity of traction. These drive toward initial medical management of PDR and DME but fail to specify traction severity for surgical priority. Main logical issue: A unique best answer (A, anti-VEGF) exists as first-line for regressing neovascularization and reducing edema per guidelines, but the key is C; options discriminate well without contradictions. Main medical accuracy issues: Keyed C (vitrectomy) is not initial for PDR with DME and VMT—anti-VEGF is standard (e.g., AAO, DRCR.net); vitrectomy is reserved for severe traction, non-clearing VH, or tractional RD involving macula. Item implies inaccurate prioritization, potentially misleading on management sequence; corticosteroids risk complications in diabetics. Minimal fix: Change keyed answer to A (intravitreal anti-VEGF injection).\",\n  \"medical_accuracy_score\": 2,\n  \"logical_validity\": false,\n  \"logical_false_reason\": \"K\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K. Verdict on keyed answer: Miskeyed. The clinical problem is determining the most appropriate initial treatment for a 60-year-old diabetic man with sudden painless right eye vision loss, macular edema, disc neovascularization, and vitreomacular traction on OCT, consistent with proliferative diabetic retinopathy (PDR) and diabetic macular edema (DME) with traction. Key stem clues: diabetes history, acute painless vision loss, fundoscopic macular edema and NVD, OCT-confirmed VMT; no mention of vitreous hemorrhage, tractional retinal detachment, or severity of traction. These drive toward initial medical management of PDR and DME but fail to specify traction severity for surgical priority. Main logical issue: A unique best answer (A, anti-VEGF) exists as first-line for regressing neovascularization and reducing edema per guidelines, but the key is C; options discriminate well without contradictions. Main medical accuracy issues: Keyed C (vitrectomy) is not initial for PDR with DME and VMT—anti-VEGF is standard (e.g., AAO, DRCR.net); vitrectomy is reserved for severe traction, non-clearing VH, or tractional RD involving macula. Item implies inaccurate prioritization, potentially misleading on management sequence; corticosteroids risk complications in diabetics. Minimal fix: Change keyed answer to A (intravitreal anti-VEGF injection).", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-006", "question": "A 25-year-old athlete sustains a tibial plateau fracture with associated meniscal tear and ACL disruption. Intraoperative findings include a depressed lateral plateau fragment. What is the optimal surgical approach to restore joint congruity?", "options": ["External fixation with delayed internal fixation", "Arthroscopic-assisted reduction and internal fixation", "Open reduction with bone grafting and buttress plating", "Total knee arthroplasty", "Nonoperative management with bracing"], "answer": "C", "answer_index": 2, "explanation": "Open reduction with bone grafting and buttress plating restores articular surface in complex tibial plateau fractures with depression. Arthroscopic assistance is for simpler cases, external fixation is temporary, arthroplasty is for older patients, and nonoperative risks malunion.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Orthopedic Surgery", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues that drive a unique best answer: 25-year-old athlete with tibial plateau fracture, depressed lateral plateau fragment, associated meniscal tear and ACL disruption; question focuses on optimal surgical approach to restore joint congruity. These clues indicate a complex intra-articular fracture in a young, active patient requiring precise articular restoration to prevent long-term arthritis and support return to activity.\\nMain logical issue(s), if any: None; the stem provides sufficient details to discriminate options without contradictions or underspecification, supporting C as the unique best choice for addressing depression via open access, grafting, and stable fixation.\\nMain medical accuracy issue(s), if any: None; aligns with orthopedic consensus (e.g., AAOS guidelines) for Schatzker type fractures with depression—ORIF with bone grafting and buttress plating is standard for young patients to restore anatomy, while alternatives like arthroscopy suit minimally displaced cases, external fixation is temporizing, arthroplasty is for salvage in elderly/arthritic knees, and nonoperative risks malunion/instability.\\nMinimal fix: N/A; item is already unambiguous and accurate, though adding 'Schatzker IV' classification could enhance specificity without altering intent.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues that drive a unique best answer: 25-year-old athlete with tibial plateau fracture, depressed lateral plateau fragment, associated meniscal tear and ACL disruption; question focuses on optimal surgical approach to restore joint congruity. These clues indicate a complex intra-articular fracture in a young, active patient requiring precise articular restoration to prevent long-term arthritis and support return to activity.\nMain logical issue(s), if any: None; the stem provides sufficient details to discriminate options without contradictions or underspecification, supporting C as the unique best choice for addressing depression via open access, grafting, and stable fixation.\nMain medical accuracy issue(s), if any: None; aligns with orthopedic consensus (e.g., AAOS guidelines) for Schatzker type fractures with depression—ORIF with bone grafting and buttress plating is standard for young patients to restore anatomy, while alternatives like arthroscopy suit minimally displaced cases, external fixation is temporizing, arthroplasty is for salvage in elderly/arthritic knees, and nonoperative risks malunion/instability.\nMinimal fix: N/A; item is already unambiguous and accurate, though adding 'Schatzker IV' classification could enhance specificity without altering intent.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-007", "question": "A 55-year-old woman with multiple sclerosis presents with progressive spastic paraparesis and urinary incontinence. MRI shows a syrinx from C4 to T2 without Chiari malformation. What is the most likely underlying mechanism, and appropriate management?", "options": ["Post-traumatic syrinx; syringoperitoneal shunting", "Idiopathic syringomyelia; conservative monitoring", "Tumoral syrinx; biopsy and resection", "Inflammatory syrinx due to MS; high-dose steroids", "Arachnoiditis-related; laminectomy with adhesiolysis"], "answer": "A", "answer_index": 0, "explanation": "Post-traumatic syrinx in MS context likely from prior demyelination scars disrupting CSF flow, managed with shunting to prevent progression. Idiopathic lacks MS history, tumoral requires mass evidence, steroids treat acute flares not syrinx, adhesiolysis is for specific scarring.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 55-year-old woman with multiple sclerosis (MS), progressive spastic paraparesis, urinary incontinence, MRI showing syrinx from C4 to T2 without Chiari malformation. These clues point to syrinx secondary to MS-related spinal cord pathology, likely from demyelination scars disrupting CSF flow, making post-traumatic the most fitting mechanism among options, with shunting as appropriate for progressive symptoms. Main logical issue(s): None; the vignette allows discrimination, eliminating B (ignores MS history), C (no tumor evidence), D (steroids for acute MS, not syrinx management), E (no arachnoiditis indicated). Main medical accuracy issue(s): Classifying as 'post-traumatic' is somewhat nonstandard, as it typically denotes physical trauma rather than MS-induced gliosis or scarring; however, it's consistent with mechanisms of altered CSF dynamics in MS-associated syringomyelia, and shunting is a recognized option for symptomatic progression per neurosurgical guidelines. The item's logic aligns with board-level knowledge on secondary syringomyelia. Minimal fix: Revise option A to 'Syrinx secondary to MS demyelination; syringoperitoneal shunting' for clearer terminology without altering intent.\",\n  \"medical_accuracy_score\": 4,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 55-year-old woman with multiple sclerosis (MS), progressive spastic paraparesis, urinary incontinence, MRI showing syrinx from C4 to T2 without Chiari malformation. These clues point to syrinx secondary to MS-related spinal cord pathology, likely from demyelination scars disrupting CSF flow, making post-traumatic the most fitting mechanism among options, with shunting as appropriate for progressive symptoms. Main logical issue(s): None; the vignette allows discrimination, eliminating B (ignores MS history), C (no tumor evidence), D (steroids for acute MS, not syrinx management), E (no arachnoiditis indicated). Main medical accuracy issue(s): Classifying as 'post-traumatic' is somewhat nonstandard, as it typically denotes physical trauma rather than MS-induced gliosis or scarring; however, it's consistent with mechanisms of altered CSF dynamics in MS-associated syringomyelia, and shunting is a recognized option for symptomatic progression per neurosurgical guidelines. The item's logic aligns with board-level knowledge on secondary syringomyelia. Minimal fix: Revise option A to 'Syrinx secondary to MS demyelination; syringoperitoneal shunting' for clearer terminology without altering intent.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-008", "question": "A 40-year-old man with epilepsy on carbamazepine develops diplopia, ataxia, and nystagmus. Serum levels are therapeutic, but free fraction is elevated. What is the most likely cause, and adjustment needed?", "options": ["Hyponatremia; restrict fluids", "Drug interaction with protein binding; reduce dose", "Autoinduction; increase dose", "Hepatic failure; switch to alternative", "Renal impairment; hemodialysis"], "answer": "B", "answer_index": 1, "explanation": "Elevated free carbamazepine due to hypoalbuminemia or displacement increases toxicity despite therapeutic total levels, requiring dose reduction. Hyponatremia causes different symptoms, autoinduction lowers levels, hepatic failure elevates total levels, renal issues don't directly affect binding.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. The clinical problem is carbamazepine toxicity (diplopia, ataxia, nystagmus) despite therapeutic total serum levels but with elevated free fraction, asking for most likely cause and adjustment. Key stem clues: epilepsy treated with carbamazepine, toxicity symptoms, therapeutic total levels, elevated free fraction—these drive toward altered protein binding as the cause, uniquely supporting B (drug interaction displacing carbamazepine from proteins, increasing free fraction and toxicity, requiring dose reduction). No main logical issues; the vignette is coherent, allows discrimination among options, and identifies B as the single best without unstated assumptions. Alternatives are inferior: A (hyponatremia) presents differently and unrelated to free fraction; C (autoinduction) lowers levels, contradicting toxicity; D (hepatic failure) typically elevates total levels, not matching therapeutic totals; E (renal impairment) irrelevant as carbamazepine is hepatically metabolized and bound, not renally cleared. No main medical accuracy issues; aligns with standard pharmacology—carbamazepine is 70-80% protein-bound, displacement (e.g., by valproate) elevates free levels causing toxicity at normal totals, per guidelines like UpToDate and board exams. Minimal fix: None needed; item is unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. The clinical problem is carbamazepine toxicity (diplopia, ataxia, nystagmus) despite therapeutic total serum levels but with elevated free fraction, asking for most likely cause and adjustment. Key stem clues: epilepsy treated with carbamazepine, toxicity symptoms, therapeutic total levels, elevated free fraction—these drive toward altered protein binding as the cause, uniquely supporting B (drug interaction displacing carbamazepine from proteins, increasing free fraction and toxicity, requiring dose reduction). No main logical issues; the vignette is coherent, allows discrimination among options, and identifies B as the single best without unstated assumptions. Alternatives are inferior: A (hyponatremia) presents differently and unrelated to free fraction; C (autoinduction) lowers levels, contradicting toxicity; D (hepatic failure) typically elevates total levels, not matching therapeutic totals; E (renal impairment) irrelevant as carbamazepine is hepatically metabolized and bound, not renally cleared. No main medical accuracy issues; aligns with standard pharmacology—carbamazepine is 70-80% protein-bound, displacement (e.g., by valproate) elevates free levels causing toxicity at normal totals, per guidelines like UpToDate and board exams. Minimal fix: None needed; item is unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-009", "question": "A 35-year-old woman presents with erythematous plaques on the trunk and positive Darier's sign. Biopsy shows mast cell infiltration. Systemic symptoms include flushing and diarrhea. What is the most appropriate long-term management?", "options": ["Oral cromolyn sodium", "Imatinib therapy", "Omalizumab injections", "Bone marrow transplantation", "Interferon-alpha"], "answer": "A", "answer_index": 0, "explanation": "Oral cromolyn stabilizes mast cells in cutaneous mastocytosis with systemic features, reducing mediator release. Imatinib is for KIT mutations not present here, omalizumab for allergic components, transplantation for aggressive forms, interferon for indolent systemic mastocytosis.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Dermatology", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include erythematous plaques on the trunk, positive Darier's sign (indicating mast cell degranulation), skin biopsy showing mast cell infiltration (consistent with cutaneous mastocytosis, likely urticaria pigmentosa), and systemic symptoms of flushing and diarrhea (suggesting mediator release and possible systemic involvement). These findings imply indolent mast cell disease requiring symptomatic long-term management to stabilize mast cells and reduce symptoms. The keyed answer A (oral cromolyn sodium) fits as it prevents mast cell degranulation and alleviates GI and flushing symptoms per standard guidelines. Alternatives are inferior: B (imatinib) requires specific KIT mutations not mentioned; C (omalizumab) targets IgE-mediated allergy, not primary here; D (bone marrow transplantation) is for aggressive systemic mastocytosis, unsupported by mild symptoms; E (interferon-alpha) is for refractory indolent cases, not first-line. No main logical issues; stem allows discrimination without contradictions or underspecification, as symptoms and biopsy support symptomatic management over targeted or aggressive therapies. No main medical accuracy issues; aligns with current guidelines (e.g., cromolyn for symptomatic mastocytosis per NCCN/AAAAI). Minimal fix: None needed; item is unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include erythematous plaques on the trunk, positive Darier's sign (indicating mast cell degranulation), skin biopsy showing mast cell infiltration (consistent with cutaneous mastocytosis, likely urticaria pigmentosa), and systemic symptoms of flushing and diarrhea (suggesting mediator release and possible systemic involvement). These findings imply indolent mast cell disease requiring symptomatic long-term management to stabilize mast cells and reduce symptoms. The keyed answer A (oral cromolyn sodium) fits as it prevents mast cell degranulation and alleviates GI and flushing symptoms per standard guidelines. Alternatives are inferior: B (imatinib) requires specific KIT mutations not mentioned; C (omalizumab) targets IgE-mediated allergy, not primary here; D (bone marrow transplantation) is for aggressive systemic mastocytosis, unsupported by mild symptoms; E (interferon-alpha) is for refractory indolent cases, not first-line. No main logical issues; stem allows discrimination without contradictions or underspecification, as symptoms and biopsy support symptomatic management over targeted or aggressive therapies. No main medical accuracy issues; aligns with current guidelines (e.g., cromolyn for symptomatic mastocytosis per NCCN/AAAAI). Minimal fix: None needed; item is unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-010", "question": "A 55-year-old man with prostate cancer on androgen deprivation therapy develops urinary retention. Cystoscopy reveals bladder neck contracture. What is the most effective definitive treatment?", "options": ["Transurethral incision of the bladder neck", "Suprapubic catheter placement", "Alpha-blocker therapy", "Intravesical botulinum toxin injection", "Urethral dilation with sounds"], "answer": "A", "answer_index": 0, "explanation": "Transurethral incision relieves bladder neck contracture post-ADT, providing durable relief. Suprapubic catheter is palliative, alpha-blockers ineffective for scarring, botulinum for detrusor issues, dilation temporary and recurrent.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Urology", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include a 55-year-old man with prostate cancer on androgen deprivation therapy (ADT) developing urinary retention, with cystoscopy confirming bladder neck contracture—a fibrotic scarring often associated with ADT or post-treatment changes. This points to a fixed mechanical obstruction requiring definitive intervention. The question asks for the most effective definitive treatment, making transurethral incision (A) the best choice as it directly addresses the contracture with durable relief, per urologic standards. Alternatives are inferior: suprapubic catheter (B) is palliative for symptom management, not curative; alpha-blockers (C) target dynamic obstruction like BPH, ineffective for scarring; intravesical botulinum toxin (D) treats detrusor overactivity, not contracture; urethral dilation (E) offers temporary relief with high recurrence. No main logical issues; stem is sufficient without contradictions, allowing discrimination of a single best answer. No main medical accuracy issues; aligns with current guidelines (e.g., AUA) on bladder neck contracture management post-ADT, where TUIBN is preferred for definitive repair. Minimal fix: None required, as item is unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include a 55-year-old man with prostate cancer on androgen deprivation therapy (ADT) developing urinary retention, with cystoscopy confirming bladder neck contracture—a fibrotic scarring often associated with ADT or post-treatment changes. This points to a fixed mechanical obstruction requiring definitive intervention. The question asks for the most effective definitive treatment, making transurethral incision (A) the best choice as it directly addresses the contracture with durable relief, per urologic standards. Alternatives are inferior: suprapubic catheter (B) is palliative for symptom management, not curative; alpha-blockers (C) target dynamic obstruction like BPH, ineffective for scarring; intravesical botulinum toxin (D) treats detrusor overactivity, not contracture; urethral dilation (E) offers temporary relief with high recurrence. No main logical issues; stem is sufficient without contradictions, allowing discrimination of a single best answer. No main medical accuracy issues; aligns with current guidelines (e.g., AUA) on bladder neck contracture management post-ADT, where TUIBN is preferred for definitive repair. Minimal fix: None required, as item is unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-011", "question": "A 28-year-old pregnant woman at 32 weeks gestation with major depressive disorder relapses after stopping sertraline. She has suicidal ideation. What is the most appropriate pharmacologic intervention?", "options": ["Restart sertraline at previous dose", "Initiate electroconvulsive therapy", "Start bupropion extended-release", "Prescribe mirtazapine", "Use transcranial magnetic stimulation"], "answer": "B", "answer_index": 1, "explanation": "ECT is safe and effective for severe depression in pregnancy with suicidality, avoiding fetal medication exposure. Sertraline risks neonatal adaptation syndrome, bupropion seizure risk, mirtazapine sedation, TMS less evidence in acute suicidality.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: C (primary; secondary U leading to M). Verdict on keyed answer: Not uniquely determinable. Key stem clues: 28-year-old at 32 weeks gestation, relapsed major depressive disorder after stopping sertraline, with suicidal ideation; question seeks most appropriate pharmacologic intervention. Main logical issue(s): Contradiction in stem specifying 'pharmacologic intervention' while options include non-pharmacologic treatments (B: ECT, E: TMS), and keyed answer B is non-pharmacologic, rendering the item incoherent and unsolvable as phrased; this underspecification allows multiple defensible interpretations (e.g., A as best pharmacologic vs. B as overall best for suicidality). Main medical accuracy issue(s): Implied logic favoring ECT for severe depression with suicidality in pregnancy is consistent with mainstream guidelines (e.g., APA, ACOG), emphasizing safety and efficacy without fetal drug exposure; sertraline (A) is commonly restarted if benefits outweigh risks like neonatal adaptation syndrome, but ECT is preferred in acute high-risk cases; rationale's concerns on alternatives (C: seizure risk, D: sedation) are partially accurate but oversimplified, as these meds are sometimes used in pregnancy. Minimal fix: Revise stem to 'most appropriate intervention' by removing 'pharmacologic' to eliminate contradiction and support unique best answer B.\",\n  \"medical_accuracy_score\": 4,\n  \"logical_validity\": false,\n  \"logical_false_reason\": \"C\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: C (primary; secondary U leading to M). Verdict on keyed answer: Not uniquely determinable. Key stem clues: 28-year-old at 32 weeks gestation, relapsed major depressive disorder after stopping sertraline, with suicidal ideation; question seeks most appropriate pharmacologic intervention. Main logical issue(s): Contradiction in stem specifying 'pharmacologic intervention' while options include non-pharmacologic treatments (B: ECT, E: TMS), and keyed answer B is non-pharmacologic, rendering the item incoherent and unsolvable as phrased; this underspecification allows multiple defensible interpretations (e.g., A as best pharmacologic vs. B as overall best for suicidality). Main medical accuracy issue(s): Implied logic favoring ECT for severe depression with suicidality in pregnancy is consistent with mainstream guidelines (e.g., APA, ACOG), emphasizing safety and efficacy without fetal drug exposure; sertraline (A) is commonly restarted if benefits outweigh risks like neonatal adaptation syndrome, but ECT is preferred in acute high-risk cases; rationale's concerns on alternatives (C: seizure risk, D: sedation) are partially accurate but oversimplified, as these meds are sometimes used in pregnancy. Minimal fix: Revise stem to 'most appropriate intervention' by removing 'pharmacologic' to eliminate contradiction and support unique best answer B.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "C", "verdict": "FAIL", "fail_reason": "C"}, "judge_verdict": "FAIL", "judge_fail_reason": "C", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-012", "question": "A 60-year-old man with alcohol use disorder presents with confabulation, ophthalmoplegia, and ataxia. MRI shows mamillary body atrophy. What is the underlying deficiency, and specific treatment?", "options": ["Vitamin B12; intramuscular cyanocobalamin", "Thiamine; intravenous thiamine", "Folate; oral folic acid", "Vitamin E; alpha-tocopherol", "Magnesium; intravenous magnesium sulfate"], "answer": "B", "answer_index": 1, "explanation": "Thiamine deficiency causes Wernicke-Korsakoff syndrome, treated urgently with IV thiamine to prevent irreversible damage. B12 deficiency causes subacute combined degeneration, folate anemia, vitamin E ataxia without confabulation, magnesium tremors not ophthalmoplegia.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include alcohol use disorder, confabulation (Korsakoff psychosis), ophthalmoplegia and ataxia (Wernicke encephalopathy), and MRI showing mamillary body atrophy, classic for thiamine deficiency in Wernicke-Korsakoff syndrome. These findings discriminate B (thiamine; IV thiamine) as the best, aligning with urgent treatment to prevent irreversible damage. No main logical issues; the vignette is coherent, non-contradictory, and specifies details allowing a single best choice without unstated assumptions. No main medical accuracy issues; consistent with current guidelines (e.g., IV thiamine as first-line for suspected Wernicke in alcoholics, per American Society of Addiction Medicine and neurology standards). Alternatives are appropriately inferior: A fits B12 deficiency (e.g., subacute combined degeneration with paresthesias, not confabulation); C suits folate deficiency anemia; D matches vitamin E deficiency ataxia without encephalopathy; E aligns with hypomagnesemia tremors, lacking ophthalmoplegia. Minimal fix: No edit required; item is already unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include alcohol use disorder, confabulation (Korsakoff psychosis), ophthalmoplegia and ataxia (Wernicke encephalopathy), and MRI showing mamillary body atrophy, classic for thiamine deficiency in Wernicke-Korsakoff syndrome. These findings discriminate B (thiamine; IV thiamine) as the best, aligning with urgent treatment to prevent irreversible damage. No main logical issues; the vignette is coherent, non-contradictory, and specifies details allowing a single best choice without unstated assumptions. No main medical accuracy issues; consistent with current guidelines (e.g., IV thiamine as first-line for suspected Wernicke in alcoholics, per American Society of Addiction Medicine and neurology standards). Alternatives are appropriately inferior: A fits B12 deficiency (e.g., subacute combined degeneration with paresthesias, not confabulation); C suits folate deficiency anemia; D matches vitamin E deficiency ataxia without encephalopathy; E aligns with hypomagnesemia tremors, lacking ophthalmoplegia. Minimal fix: No edit required; item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-013", "question": "A 42-year-old woman undergoes Whipple procedure for pancreatic adenocarcinoma. Postoperatively, she develops delayed gastric emptying with high nasogastric output. What is the most effective prokinetic agent?", "options": ["Metoclopramide intravenously", "Erythromycin orally", "Domperidone orally", "Prucalopride", "Octreotide subcutaneously"], "answer": "B", "answer_index": 1, "explanation": "Erythromycin acts as a motilin agonist to enhance gastric motility in post-Whipple delayed emptying. Metoclopramide risks tardive dyskinesia, domperidone cardiac issues, prucalopride for colon, octreotide inhibits motility.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 42-year-old woman post-Whipple for pancreatic adenocarcinoma with delayed gastric emptying and high nasogastric output, implying need for effective prokinetic to enhance gastric motility without major risks. The question asks for the most effective prokinetic agent in this context. Erythromycin (B) fits as a motilin agonist proven to improve gastric emptying post-pancreaticoduodenectomy. Alternatives are inferior: Metoclopramide (A) has tardive dyskinesia risk with prolonged use; Domperidone (C) carries cardiac QT prolongation risks and limited availability; Prucalopride (D) primarily acts on colonic motility, not gastric; Octreotide (E) inhibits GI motility, worsening the condition. No main logical issues; stem allows clear discrimination with one best option matching the key. Main medical accuracy issues: None; aligns with current guidelines (e.g., erythromycin's use in post-op DGE per surgical literature, while noting side effects of others). Item is clinically realistic and board-relevant. Minimal fix: Not needed, but could add 'in the United States' to stem for domperidone context if emphasizing regional standards.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 42-year-old woman post-Whipple for pancreatic adenocarcinoma with delayed gastric emptying and high nasogastric output, implying need for effective prokinetic to enhance gastric motility without major risks. The question asks for the most effective prokinetic agent in this context. Erythromycin (B) fits as a motilin agonist proven to improve gastric emptying post-pancreaticoduodenectomy. Alternatives are inferior: Metoclopramide (A) has tardive dyskinesia risk with prolonged use; Domperidone (C) carries cardiac QT prolongation risks and limited availability; Prucalopride (D) primarily acts on colonic motility, not gastric; Octreotide (E) inhibits GI motility, worsening the condition. No main logical issues; stem allows clear discrimination with one best option matching the key. Main medical accuracy issues: None; aligns with current guidelines (e.g., erythromycin's use in post-op DGE per surgical literature, while noting side effects of others). Item is clinically realistic and board-relevant. Minimal fix: Not needed, but could add 'in the United States' to stem for domperidone context if emphasizing regional standards.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-014", "question": "A 70-year-old man with diverticulitis undergoes Hartmann's procedure. Six months later, he presents for reversal but has severe cardiac comorbidity. What is the safest reversal technique?", "options": ["Laparoscopic colostomy reversal with anastomosis", "Open reversal with protective ileostomy", "Endoscopic stenting of the rectal stump", "Percutaneous endoscopic colostomy", "Continued observation"], "answer": "A", "answer_index": 0, "explanation": "Laparoscopic approach minimizes morbidity in high-risk patients for Hartmann's reversal. Open with ileostomy adds procedures, stenting not for reversal, PEC for constipation, observation avoids surgery but maintains stoma.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues that drive a unique best answer: 70-year-old man post-Hartmann's for diverticulitis, presenting for reversal with severe cardiac comorbidity; question asks for safest reversal technique. Clues emphasize high surgical risk, implying need for minimally invasive approach to minimize morbidity.\\nMain logical issue(s), if any: None; stem provides sufficient details to discriminate options without contradictions or underspecification. A is uniquely defensible as least invasive reversal method, while others are more invasive (B), irrelevant (C, D), or avoid reversal (E).\\nMain medical accuracy issue(s), if any: None; aligns with current standards favoring laparoscopic Hartmann's reversal in high-risk patients to reduce complications like wound infections and cardiac stress, per surgical guidelines (e.g., ASCRS). Rationale correctly dismisses alternatives: open with ileostomy increases morbidity, stenting/PEC not indicated for reversal, observation maintains stoma.\\nMinimal fix: No fix needed; item is already unambiguous and accurate. (If enhancing, add 'assuming no contraindications to laparoscopy' to stem for explicitness, but not required.)\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues that drive a unique best answer: 70-year-old man post-Hartmann's for diverticulitis, presenting for reversal with severe cardiac comorbidity; question asks for safest reversal technique. Clues emphasize high surgical risk, implying need for minimally invasive approach to minimize morbidity.\nMain logical issue(s), if any: None; stem provides sufficient details to discriminate options without contradictions or underspecification. A is uniquely defensible as least invasive reversal method, while others are more invasive (B), irrelevant (C, D), or avoid reversal (E).\nMain medical accuracy issue(s), if any: None; aligns with current standards favoring laparoscopic Hartmann's reversal in high-risk patients to reduce complications like wound infections and cardiac stress, per surgical guidelines (e.g., ASCRS). Rationale correctly dismisses alternatives: open with ileostomy increases morbidity, stenting/PEC not indicated for reversal, observation maintains stoma.\nMinimal fix: No fix needed; item is already unambiguous and accurate. (If enhancing, add 'assuming no contraindications to laparoscopy' to stem for explicitness, but not required.)", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-015", "question": "A 45-year-old woman with rheumatoid arthritis on methotrexate develops corneal melt and peripheral ulcerative keratitis. What is the most appropriate immunosuppressive therapy adjustment?", "options": ["Add infliximab infusion", "Switch to rituximab", "Initiate cyclophosphamide", "Topical cyclosporine", "Systemic corticosteroids with azathioprine"], "answer": "C", "answer_index": 2, "explanation": "Cyclophosphamide is used for severe ocular manifestations in rheumatoid vasculitis like corneal melt. Infliximab for joints, rituximab B-cell depletion insufficient alone, topical for surface, steroids with azathioprine less potent for melt.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Ophthalmology", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 45-year-old woman with rheumatoid arthritis (RA) on methotrexate developing corneal melt and peripheral ulcerative keratitis (PUK), indicating severe ocular vasculitis refractory to current therapy, prompting aggressive immunosuppressive adjustment. These findings point to a need for potent systemic therapy for organ-threatening manifestation. Main logical issue(s): None; the stem provides sufficient details to discriminate options, with C (cyclophosphamide) as the unique best for severe RA vasculitis with corneal melt, while alternatives are less appropriate (A for articular symptoms, B insufficient for acute vasculitis alone, D topical and inadequate for deep involvement, E less potent combination). Main medical accuracy issue(s): Generally accurate per rheumatology guidelines (e.g., ACR recommendations for severe extra-articular RA); cyclophosphamide is established for necrotizing keratitis in RA vasculitis, though modern practice may also consider rituximab (B) for refractory cases, introducing minor nuance but not undermining C as best. Minimal fix: None required, but to enhance precision, add 'refractory to methotrexate and severe vision-threatening' to the stem to further emphasize urgency excluding less aggressive options like E.\",\n  \"medical_accuracy_score\": 4,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 45-year-old woman with rheumatoid arthritis (RA) on methotrexate developing corneal melt and peripheral ulcerative keratitis (PUK), indicating severe ocular vasculitis refractory to current therapy, prompting aggressive immunosuppressive adjustment. These findings point to a need for potent systemic therapy for organ-threatening manifestation. Main logical issue(s): None; the stem provides sufficient details to discriminate options, with C (cyclophosphamide) as the unique best for severe RA vasculitis with corneal melt, while alternatives are less appropriate (A for articular symptoms, B insufficient for acute vasculitis alone, D topical and inadequate for deep involvement, E less potent combination). Main medical accuracy issue(s): Generally accurate per rheumatology guidelines (e.g., ACR recommendations for severe extra-articular RA); cyclophosphamide is established for necrotizing keratitis in RA vasculitis, though modern practice may also consider rituximab (B) for refractory cases, introducing minor nuance but not undermining C as best. Minimal fix: None required, but to enhance precision, add 'refractory to methotrexate and severe vision-threatening' to the stem to further emphasize urgency excluding less aggressive options like E.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-016", "question": "A 35-year-old man sustains a humeral shaft fracture with radial nerve palsy. Exploration shows nerve entrapment in the fracture site. What is the optimal management of the nerve injury?", "options": ["Immediate nerve grafting", "Neurolysis and fracture fixation", "Nerve transfer from triceps branch", "Tendon transfer for wrist extension", "Observation with serial EMG"], "answer": "B", "answer_index": 1, "explanation": "Neurolysis frees the entrapped radial nerve during fracture fixation, allowing potential recovery. Grafting for transection, transfer for irreparable, tendon for chronic, observation misses surgical window.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Orthopedic Surgery", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 35-year-old man with humeral shaft fracture and radial nerve palsy; surgical exploration reveals nerve entrapment in fracture site, implying a Sunderland grade 1-3 injury (neurapraxia or axonotmesis) without transection, necessitating decompression for recovery. This supports neurolysis (freeing the nerve) combined with fracture fixation as optimal, aligning with orthopedic standards for acute entrapment to prevent further damage and promote regeneration. Main logical issue(s), if any: None; stem provides sufficient details for discrimination—entrapment specifies non-transected nerve, ruling out grafting (A) which is for complete severance; nerve transfer (C) for chronic/irreparable cases; tendon transfer (D) for permanent palsy; observation (E) inappropriate post-exploration as it misses intervention opportunity. Options are well-differentiated without overlap or contradiction. Main medical accuracy issue(s), if any: None; consistent with current guidelines (e.g., AAOS, OTA) emphasizing early neurolysis in entrapped radial nerve injuries during open reduction, with high recovery rates; rationale accurately distinguishes indications. Minimal fix: No edit needed; item is already unambiguous and accurate, though adding 'nerve continuity confirmed' to stem could enhance clarity without changing intent.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 35-year-old man with humeral shaft fracture and radial nerve palsy; surgical exploration reveals nerve entrapment in fracture site, implying a Sunderland grade 1-3 injury (neurapraxia or axonotmesis) without transection, necessitating decompression for recovery. This supports neurolysis (freeing the nerve) combined with fracture fixation as optimal, aligning with orthopedic standards for acute entrapment to prevent further damage and promote regeneration. Main logical issue(s), if any: None; stem provides sufficient details for discrimination—entrapment specifies non-transected nerve, ruling out grafting (A) which is for complete severance; nerve transfer (C) for chronic/irreparable cases; tendon transfer (D) for permanent palsy; observation (E) inappropriate post-exploration as it misses intervention opportunity. Options are well-differentiated without overlap or contradiction. Main medical accuracy issue(s), if any: None; consistent with current guidelines (e.g., AAOS, OTA) emphasizing early neurolysis in entrapped radial nerve injuries during open reduction, with high recovery rates; rationale accurately distinguishes indications. Minimal fix: No edit needed; item is already unambiguous and accurate, though adding 'nerve continuity confirmed' to stem could enhance clarity without changing intent.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-017", "question": "A 65-year-old man with Parkinson's disease develops impulse control disorder on pramipexole. He also has motor fluctuations. What is the most appropriate medication adjustment?", "options": ["Switch to rotigotine patch", "Add entacapone", "Initiate deep brain stimulation evaluation", "Start apomorphine subcutaneous", "Convert to levodopa-benserazide"], "answer": "D", "answer_index": 3, "explanation": "Apomorphine provides rapid relief for fluctuations and may reduce dopamine agonist dose, mitigating ICD. Rotigotine similar risk, entacapone extends levodopa, DBS for advanced, levodopa increases dyskinesia risk.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (primary; secondary U). Verdict on keyed answer: Miskeyed. Key stem clues that drive a unique best answer: 65-year-old with Parkinson's disease, impulse control disorder (ICD) developed on pramipexole, and motor fluctuations; no mention of levodopa or other concomitant medications. These clues emphasize managing ICD by adjusting the offending dopamine agonist while addressing fluctuations, but absence of levodopa detail limits options. Main logical issue(s): Miskeyed (K) because a unique best answer exists (E: Convert to levodopa-benserazide), as it directly replaces pramipexole, mitigating ICD without requiring unstated levodopa, and provides standard PD therapy; keyed D (apomorphine) is not defensible without assuming levodopa, which is a critical missing detail (secondary U), making assumptions necessary for other options like B and D. Main medical accuracy issue(s): The intended teaching point on apomorphine for fluctuations and ICD mitigation is consistent with guidelines (e.g., low ICD risk with apomorphine, allowing agonist reduction), but as written, without levodopa specified, D contradicts standard use (apomorphine typically adjunct to levodopa), potentially misleading learners on indications; other rationales (e.g., rotigotine ICD risk, levodopa dyskinesia risk) are accurate. Minimal fix: Add 'and carbidopa-levodopa' to the stem after 'on pramipexole' to specify regimen, making D the unique best.\",\n  \"medical_accuracy_score\": 3,\n  \"logical_validity\": false,\n  \"logical_false_reason\": \"K\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (primary; secondary U). Verdict on keyed answer: Miskeyed. Key stem clues that drive a unique best answer: 65-year-old with Parkinson's disease, impulse control disorder (ICD) developed on pramipexole, and motor fluctuations; no mention of levodopa or other concomitant medications. These clues emphasize managing ICD by adjusting the offending dopamine agonist while addressing fluctuations, but absence of levodopa detail limits options. Main logical issue(s): Miskeyed (K) because a unique best answer exists (E: Convert to levodopa-benserazide), as it directly replaces pramipexole, mitigating ICD without requiring unstated levodopa, and provides standard PD therapy; keyed D (apomorphine) is not defensible without assuming levodopa, which is a critical missing detail (secondary U), making assumptions necessary for other options like B and D. Main medical accuracy issue(s): The intended teaching point on apomorphine for fluctuations and ICD mitigation is consistent with guidelines (e.g., low ICD risk with apomorphine, allowing agonist reduction), but as written, without levodopa specified, D contradicts standard use (apomorphine typically adjunct to levodopa), potentially misleading learners on indications; other rationales (e.g., rotigotine ICD risk, levodopa dyskinesia risk) are accurate. Minimal fix: Add 'and carbidopa-levodopa' to the stem after 'on pramipexole' to specify regimen, making D the unique best.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-018", "question": "A 50-year-old woman with migraine presents with hemiplegic episodes and family history of similar symptoms. Genetic testing reveals CACNA1A mutation. What is the most effective prophylactic treatment?", "options": ["Verapamil extended-release", "Topiramate", "Propranolol", "Amitriptyline", "Valproate"], "answer": "A", "answer_index": 0, "explanation": "Verapamil is preferred for familial hemiplegic migraine due to calcium channel involvement. Topiramate and valproate for common migraine, propranolol beta-blockade, amitriptyline for tension overlap.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include hemiplegic episodes, family history of similar symptoms, and confirmed CACNA1A mutation, pointing to familial hemiplegic migraine (FHM) type 1, a calcium channelopathy where verapamil, a calcium channel blocker, is the preferred prophylactic due to targeted mechanism. No main logical issues; the vignette provides sufficient discriminating details (genetic confirmation, hemiplegic features) to identify verapamil as uniquely best without contradictions or underspecification. Main medical accuracy: Consistent with current guidelines (e.g., American Headache Society); verapamil is evidence-based for FHM prophylaxis, while alternatives like topiramate, propranolol, amitriptyline, and valproate are standard for common migraines but lack specificity for CACNA1A-related pathology. No inaccuracies or outdated elements; item aligns with board-level knowledge on channelopathies and migraine variants. Minimal fix: None needed, as the item is already unambiguous and accurate; however, to enhance precision, add 'familial hemiplegic migraine' explicitly in the stem for clarity (though not required).\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include hemiplegic episodes, family history of similar symptoms, and confirmed CACNA1A mutation, pointing to familial hemiplegic migraine (FHM) type 1, a calcium channelopathy where verapamil, a calcium channel blocker, is the preferred prophylactic due to targeted mechanism. No main logical issues; the vignette provides sufficient discriminating details (genetic confirmation, hemiplegic features) to identify verapamil as uniquely best without contradictions or underspecification. Main medical accuracy: Consistent with current guidelines (e.g., American Headache Society); verapamil is evidence-based for FHM prophylaxis, while alternatives like topiramate, propranolol, amitriptyline, and valproate are standard for common migraines but lack specificity for CACNA1A-related pathology. No inaccuracies or outdated elements; item aligns with board-level knowledge on channelopathies and migraine variants. Minimal fix: None needed, as the item is already unambiguous and accurate; however, to enhance precision, add 'familial hemiplegic migraine' explicitly in the stem for clarity (though not required).", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-019", "question": "A 40-year-old man with HIV on antiretroviral therapy develops violaceous plaques on the legs. Biopsy shows spindle cells and HHV-8 positivity. What is the most appropriate systemic therapy?", "options": ["Liposomal doxorubicin", "Interferon-alpha", "Thalidomide", "Sirolimus", "Rituximab"], "answer": "D", "answer_index": 3, "explanation": "Sirolimus inhibits mTOR in AIDS-related Kaposi sarcoma, reducing progression in immunocompromised patients. Doxorubicin for advanced, interferon immunomodulation, thalidomide anti-angiogenic but toxic, rituximab for lymphoid.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Dermatology", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K. Verdict on keyed answer: Miskeyed. Key stem clues include HIV on antiretroviral therapy, violaceous plaques on legs, biopsy showing spindle cells and HHV-8 positivity, pointing to AIDS-related Kaposi sarcoma (KS) requiring systemic therapy. Main logical issue: While the item supports a unique best answer (liposomal doxorubicin as standard first-line for advanced AIDS-related KS per guidelines like NCCN), the provided key (sirolimus) mismatches it, fitting the 'miskeyed' definition. No contradictions or underspecification; options allow discrimination, but key is wrong. Main medical accuracy issues: Sirolimus inhibits mTOR and has evidence in transplant-associated KS, but it's not the most appropriate for HIV-related KS, where optimizing ART is primary, and liposomal doxorubicin is preferred for systemic treatment in symptomatic or advanced cases; rationale overstates sirolimus's role in AIDS-KS while downplaying doxorubicin. Interferon-alpha and thalidomide have limited, non-standard use; rituximab is irrelevant. Item's implied logic contains inaccuracy by promoting sirolimus over established chemotherapy. Minimal fix: Change the keyed answer to A (liposomal doxorubicin) to align with mainstream standards.\",\n  \"medical_accuracy_score\": 2,\n  \"logical_validity\": false,\n  \"logical_false_reason\": \"K\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K. Verdict on keyed answer: Miskeyed. Key stem clues include HIV on antiretroviral therapy, violaceous plaques on legs, biopsy showing spindle cells and HHV-8 positivity, pointing to AIDS-related Kaposi sarcoma (KS) requiring systemic therapy. Main logical issue: While the item supports a unique best answer (liposomal doxorubicin as standard first-line for advanced AIDS-related KS per guidelines like NCCN), the provided key (sirolimus) mismatches it, fitting the 'miskeyed' definition. No contradictions or underspecification; options allow discrimination, but key is wrong. Main medical accuracy issues: Sirolimus inhibits mTOR and has evidence in transplant-associated KS, but it's not the most appropriate for HIV-related KS, where optimizing ART is primary, and liposomal doxorubicin is preferred for systemic treatment in symptomatic or advanced cases; rationale overstates sirolimus's role in AIDS-KS while downplaying doxorubicin. Interferon-alpha and thalidomide have limited, non-standard use; rituximab is irrelevant. Item's implied logic contains inaccuracy by promoting sirolimus over established chemotherapy. Minimal fix: Change the keyed answer to A (liposomal doxorubicin) to align with mainstream standards.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "question_id": "20251216T182308874Z_grok-4-0709_seed129-020", "question": "A 60-year-old man with chronic kidney disease stage 4 presents with hematuria and flank pain. Imaging shows a Bosniak IV cyst with enhancing nodule. What is the most appropriate management?", "options": ["Partial nephrectomy", "Active surveillance", "Radiofrequency ablation", "Percutaneous biopsy", "Radical nephrectomy"], "answer": "A", "answer_index": 0, "explanation": "Partial nephrectomy preserves renal function in CKD while addressing malignant potential of Bosniak IV cyst. Surveillance for lower categories, ablation for small tumors, biopsy diagnostic not therapeutic, radical sacrifices nephrons.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Urology", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: CKD stage 4 necessitates nephron preservation; symptomatic hematuria and flank pain suggest need for intervention; Bosniak IV cyst with enhancing nodule indicates high malignancy risk (~90-100%), warranting surgical management over surveillance or biopsy. Main logical issue(s): None; the vignette provides sufficient details to discriminate options without contradictions or underspecification, supporting partial nephrectomy as the single best choice for balancing oncologic control and renal function preservation. Main medical accuracy issue(s): None; aligns with AUA guidelines for Bosniak IV cysts (surgical excision recommended due to malignant potential) and nephron-sparing approaches in advanced CKD to avoid dialysis progression. The rationale correctly notes surveillance for lower Bosniak categories, ablation suitability for small lesions, biopsy's diagnostic role, and radical nephrectomy's nephron loss. Minimal fix: None required; item is unambiguous and accurate as written. Clinical problem: Management of likely malignant renal cyst in CKD patient. Discriminating findings: Advanced CKD, symptoms, Bosniak IV with enhancement. Implied: Nephron-sparing surgery. Keyed answer fits without assumptions. Alternatives: B worse for high-risk cyst; C for smaller/non-cystic; D not therapeutic; E sacrifices function.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: CKD stage 4 necessitates nephron preservation; symptomatic hematuria and flank pain suggest need for intervention; Bosniak IV cyst with enhancing nodule indicates high malignancy risk (~90-100%), warranting surgical management over surveillance or biopsy. Main logical issue(s): None; the vignette provides sufficient details to discriminate options without contradictions or underspecification, supporting partial nephrectomy as the single best choice for balancing oncologic control and renal function preservation. Main medical accuracy issue(s): None; aligns with AUA guidelines for Bosniak IV cysts (surgical excision recommended due to malignant potential) and nephron-sparing approaches in advanced CKD to avoid dialysis progression. The rationale correctly notes surveillance for lower Bosniak categories, ablation suitability for small lesions, biopsy's diagnostic role, and radical nephrectomy's nephron loss. Minimal fix: None required; item is unambiguous and accurate as written. Clinical problem: Management of likely malignant renal cyst in CKD patient. Discriminating findings: Advanced CKD, symptoms, Bosniak IV with enhancement. Implied: Nephron-sparing surgery. Keyed answer fits without assumptions. Alternatives: B worse for high-risk cyst; C for smaller/non-cystic; D not therapeutic; E sacrifices function.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]